SurgLine International, Inc.
SGLN · OTC
7/31/2012 | 4/30/2012 | 1/31/2012 | 10/31/2011 | |
|---|---|---|---|---|
| Market Cap | $3 | $2 | $8 | $8 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $3 | $3 | $8 | $9 |
| Revenue | -$0 | $0 | $0 | $0 |
| % Growth | -134.6% | -42.6% | -63% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | 231.2% | 63.5% | 21.2% | 47.6% |
| EBITDA | -$1 | -$0 | -$0 | -$2 |
| % Margin | 9,387.7% | -296.1% | -527.4% | -2,302.4% |
| Net Income | -$0 | -$0 | -$1 | -$2 |
| % Margin | 4,597.8% | -1,078.2% | -1,827.9% | -2,392.3% |
| EPS Diluted | -0 | -0 | -0 | -0.01 |
| % Growth | -47.5% | 67.7% | 99% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |